Oculus Innovative Sciences, Inc. (OCLS) IPO Analysis: Six Month Review  
8/13/2007 11:36:40 AM

PharmaTracker submits: Oculus Innovative Sciences, Inc. (OCLS) is a recent IPO that is developing a product for the treatment of chronic wounds, Microcyn, which they call “stable super-oxidized water.” · The active chemicals in Microcyn are hypochlorous acid and sodium hypochlorite, commonly available disinfectants found in household bleach, swimming pools and tap water.